Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report.

Haruhiko YamazakiKatsuhiko MasudoSachie KanadaYoshiaki InayamaHiroyuki HayashiYu FujiiYasushi Rino

Published in: Surgical case reports (2023)

The findings in the present case indicate that lenvatinib may have significant antitumor effects in preoperative settings. Lenvatinib may represent a promising candidate therapy for unresectable ATC by increasing tumor resectability.

Keyphrases

minimally invasive
coronary artery bypass
patients undergoing
squamous cell carcinoma
radiation therapy
combination therapy
liver metastases
coronary artery disease
acute coronary syndrome
atrial fibrillation
percutaneous coronary intervention